Last Updated: June 22, 2026

List of Excipients in API apraclonidine hydrochloride ophthalmic solution

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing apraclonidine hydrochloride ophthalmic solution

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Harrow Eye LLC	IOPIDINE 1%	apraclonidine hydrochloride ophthalmic solution	82667-200	BENZALKONIUM CHLORIDE
Harrow Eye LLC	IOPIDINE 1%	apraclonidine hydrochloride ophthalmic solution	82667-200	HYDROCHLORIC ACID
Harrow Eye LLC	IOPIDINE 1%	apraclonidine hydrochloride ophthalmic solution	82667-200	SODIUM ACETATE
Harrow Eye LLC	IOPIDINE 1%	apraclonidine hydrochloride ophthalmic solution	82667-200	SODIUM CHLORIDE
Harrow Eye LLC	IOPIDINE 1%	apraclonidine hydrochloride ophthalmic solution	82667-200	SODIUM HYDROXIDE
Harrow Eye LLC	IOPIDINE 1%	apraclonidine hydrochloride ophthalmic solution	82667-200	WATER
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for apraclonidine hydrochloride ophthalmic solution

Excipient focus: BENZALKONIUM CHLORIDE

apraclonidine hydrochloride ophthalmic solution drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Harrow Eye LLC	apraclonidine hydrochloride ophthalmic solution	82667-200
>Company	>Ingredient	>NDC

apraclonidine hydrochloride ophthalmic solution drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

apraclonidine hydrochloride ophthalmic solution drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Harrow Eye LLC	apraclonidine hydrochloride ophthalmic solution	82667-200
>Company	>Ingredient	>NDC

apraclonidine hydrochloride ophthalmic solution drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM ACETATE

apraclonidine hydrochloride ophthalmic solution drug variants containing SODIUM ACETATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Harrow Eye LLC	apraclonidine hydrochloride ophthalmic solution	82667-200
>Company	>Ingredient	>NDC

apraclonidine hydrochloride ophthalmic solution drug variants not containing SODIUM ACETATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

apraclonidine hydrochloride ophthalmic solution drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Harrow Eye LLC	apraclonidine hydrochloride ophthalmic solution	82667-200
>Company	>Ingredient	>NDC

apraclonidine hydrochloride ophthalmic solution drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

apraclonidine hydrochloride ophthalmic solution drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Harrow Eye LLC	apraclonidine hydrochloride ophthalmic solution	82667-200
>Company	>Ingredient	>NDC

apraclonidine hydrochloride ophthalmic solution drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

apraclonidine hydrochloride ophthalmic solution drug variants containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Harrow Eye LLC	apraclonidine hydrochloride ophthalmic solution	82667-200
>Company	>Ingredient	>NDC

apraclonidine hydrochloride ophthalmic solution drug variants not containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.